US biotech firm announces ‘positive interim’ results in first clinical tests of virus vaccine

WASHINGTON — US biotech firm Moderna reports “positive interim” results in the first clinical tests of its vaccine against the new coronavirus performed on a small number of volunteers.

The vaccine appears to produce an immune response in eight people who received it, of the same amplitude as that observed in people infected with the virus, the company says, adding that phase 3 trials with a large number of volunteers would begin in July.

— AFP

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.